大學光

-3.00 (-2.19%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

134.00292成交張數9.92本益比2.93股價淨值比5.78%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	64	39	39.0%	1.36	45.72	31.7%	18.9%	4.0	3.2
2026Q1	65	37	42.2%	1.91	43.13	27.4%	15.1%	5.4	4.8
2025Q4	61	40	31.7%	2.92	47.48	27.3%	17.6%	5.2	3.6
2025Q3	59	37	34.9%	2.46	43.87	27.8%	16.8%	3.2	1.9
2025Q2	57	34	38.6%	2.10	39.63	27.3%	16.6%	2.4	0.9
2025Q1	62	34	43.7%	1.78	39.61	36.1%	19.4%	5.8	5.1
2024Q4	58	36	34.8%	2.61	42.75	31.3%	19.6%	4.9	3.7
2024Q3	58	34	39.5%	2.05	39.98	33.9%	20.2%	4.3	2.7
2024Q2	50	31	34.8%	2.53	37.08	37.7%	21.9%	2.8	1.8
2024Q1	54	29	44.2%	1.74	33.76	40.8%	21.1%	4.8	4.2
2023Q4	51	32	34.8%	2.52	37.51	35.8%	21.7%	4.5	3.8
2023Q3	48	30	34.4%	2.58	35.21	38.3%	23.0%	3.3	2.0
2023Q2	50	27	42.4%	1.90	33.79	39.7%	21.6%	3.1	1.9
2023Q1	49	25	46.1%	1.71	30.67	40.3%	20.2%	4.6	3.8
2022Q4	45	27	37.0%	2.37	33.32	35.0%	20.6%	3.7	2.5
2022Q3	42	24	37.9%	2.34	30.34	35.7%	20.5%	2.7	0.9
2022Q2	40	22	41.1%	1.98	29.10	35.2%	19.0%	2.4	1.5
2022Q1	41	20	46.4%	1.67	26.73	34.9%	18.0%	3.8	3.1
2021Q4	37	22	37.9%	2.43	28.75	29.0%	17.2%	3.5	3.2
2021Q3	35	20	39.4%	2.22	26.28	28.5%	16.2%	3.2	2.7
2021Q2	36	19	43.7%	1.87	24.53	31.7%	17.2%	0.8	0.4
2021Q1	33	17	42.6%	1.71	22.89	33.2%	18.1%	1.5	1.0
2020Q4	32	19	35.6%	2.18	25.14	27.6%	16.6%	2.7	1.5
2020Q3	31	18	39.1%	1.95	23.41	25.4%	14.6%	2.2	1.4
2020Q2	29	16	40.6%	1.89	21.53	20.5%	11.5%	1.6	1.1
2020Q1	27	15	40.9%	1.85	20.07	18.4%	10.3%	1.8	1.4
2019Q4	26	16	36.0%	2.32	20.91	15.5%	10.0%	1.1	0.1
2019Q3	26	15	37.7%	2.19	20.24	15.3%	9.6%	1.6	1.2
2019Q2	27	15	40.2%	2.09	19.73	14.8%	8.8%	0.6	0.1
2019Q1	27	15	39.1%	2.17	20.03	12.7%	7.9%	0.9	0.7
2018Q4	21	15	23.3%	2.74	19.40	11.2%	7.9%	1.0	0.6
2018Q3	21	14	24.1%	2.67	18.69	10.3%	7.2%	0.6	0.1
2018Q2	21	14	27.9%	2.36	18.19	10.7%	7.3%	0.8	0.4
2018Q1	20	14	21.1%	3.13	18.78	10.1%	7.0%	0.4	-0.2
2017Q4	20	14	21.0%	3.25	18.48	9.4%	6.4%	0.5	0.2
2017Q3	19	14	21.3%	3.30	18.07	10.6%	7.2%	0.8	0.3
2017Q2	18	13	25.3%	2.69	17.51	8.3%	5.6%	0.6	0.4
2017Q1	17	12	31.9%	2.02	17.59	8.3%	5.4%	0.5	0.2
2016Q4	17	12	33.5%	1.94	17.54	–	–	0.8	0.4
2016Q3	17	11	36.1%	1.84	16.84	–	–	0.4	0.1